🇺🇸 FDA
Pipeline program

0.9% sodium chloride, GB-0895

GB-0895-301

Phase 3 small_molecule active

Quick answer

0.9% sodium chloride, GB-0895 for severe uncontrolled asthma is a Phase 3 program (small_molecule) at Generate Biomedicines with 1 ClinicalTrials.gov record(s).

Program details

Company
Generate Biomedicines
Indication
severe uncontrolled asthma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials